Healthcare information provider Wolters Kluwer Health (WK Health), US, and the Crohn's & Colitis Foundation of America, Inc. (CCFA) have announced an agreement to publish the journal Inflammatory Bowel Diseases. Effective with the January 2013 issue, Lippincott Williams & Wilkins (LWW), part of Wolters Kluwer Health, will be the journal's publisher of record.
Inflammatory Bowel Diseases (IBD), the official journal of the CCFA, is the first journal dedicated exclusively to IBD. The journal covers topics of interest to the professional clinician or researcher in this burgeoning field with original, peer-reviewed articles in clinical and basic science areas, as well as invited in-depth reviews of key treatment issues and groundbreaking research. IBD covers the unique and important issues in pediatric IBD, as well as articles pertaining to adult patients.
The journal is currently available for institutional access exclusively through Ovid’s medical research platform, OvidSP, used by more than 12,000 institutions globally. Ovid is part of WK Health.
